Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marilia I F, Barbosa"'
Autor:
Amanda Alvim Negreti, Guilherme Álvaro Ferreira-Silva, Carolina Girotto Pressete, Rafael Fonseca, Caio C. Candido, Angelica E. Graminha, Antonio Carlos Doriguetto, Ester Siqueira Caixeta, João Adolfo Costa Hanemann, Angel Mauricio Castro-Gamero, Marilia I. F. Barbosa, Marta Miyazawa, Marisa Ionta
Publikováno v:
New Journal of Chemistry. 46:3325-3337
Melanoma is a highly aggressive skin cancer with a limited targeted therapy arsenal.
Autor:
Fernando R Pavan, Gustavo V Poelhsitz, Lucas V P da Cunha, Marilia I F Barbosa, Sergio R A Leite, Alzir A Batista, Sang H Cho, Scott G Franzblau, Mariana S de Camargo, Flávia A Resende, Eliana A Varanda, Clarice Q F Leite
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64242 (2013)
Rifampicin, discovered more than 50 years ago, represents the last novel class of antibiotics introduced for the first-line treatment of tuberculosis. Drugs in this class form part of a 6-month regimen that is ineffective against MDR and XDR TB, and
Externí odkaz:
https://doaj.org/article/e703023b58f14816a09d1ac4dbcf4582
Autor:
Guilherme A, Ferreira-Silva, Marina M, Ortega, Marco A, Banionis, Graciana Y, Garavelli, Felipe T, Martins, Julia S M, Dias, Cláudio, Viegas, Jaqueline C de, Oliveira, Fabio B do, Nascimento, Antonio C, Doriguetto, Marilia I F, Barbosa, Marisa, Ionta
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 44
Lung cancer is the most frequent type of cancer worldwide. In Brazil, only 14% of the patients diagnosed with lung cancer survived 5years in the last decades. Although improvements in the therapeutic approach, it is relevant to identify new chemother